BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 30151352)

  • 1. Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy.
    Wegiel B; Vuerich M; Daneshmandi S; Seth P
    Front Oncol; 2018; 8():284. PubMed ID: 30151352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
    Sasidharan Nair V; Saleh R; Toor SM; Cyprian FS; Elkord E
    Cancer Immunol Immunother; 2021 Aug; 70(8):2103-2121. PubMed ID: 33532902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma.
    Won WJ; Deshane JS; Leavenworth JW; Oliva CR; Griguer CE
    Cell Stress; 2019 Jan; 3(2):47-65. PubMed ID: 31225500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy.
    Gupta S; Roy A; Dwarakanath BS
    Front Oncol; 2017; 7():68. PubMed ID: 28447025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications.
    Tamura R; Tanaka T; Akasaki Y; Murayama Y; Yoshida K; Sasaki H
    Med Oncol; 2019 Nov; 37(1):2. PubMed ID: 31713115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment.
    Pérez-Tomás R; Pérez-Guillén I
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33153193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity.
    Hasan MN; Capuk O; Patel SM; Sun D
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty Acid Metabolism in Myeloid-Derived Suppressor Cells and Tumor-Associated Macrophages: Key Factor in Cancer Immune Evasion.
    Siddiqui S; Glauben R
    Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment.
    Mishra D; Banerjee D
    Cancers (Basel); 2019 May; 11(6):. PubMed ID: 31146503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates.
    Mohamed E; Al-Khami AA; Rodriguez PC
    Cell Mol Immunol; 2018 May; 15(5):421-427. PubMed ID: 29568118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting metabolism to enhance immunotherapy within tumor microenvironment.
    Liang XH; Chen XY; Yan Y; Cheng AY; Lin JY; Jiang YX; Chen HZ; Jin JM; Luan X
    Acta Pharmacol Sin; 2024 May; ():. PubMed ID: 38811773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
    Zhang M; Wei T; Zhang X; Guo D
    Front Immunol; 2022; 13():937406. PubMed ID: 36131916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment.
    Zerbib E; Arif T; Shteinfer-Kuzmine A; Chalifa-Caspi V; Shoshan-Barmatz V
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34200480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming the tumor microenvironment with biotechnology.
    Kim M; Lee NK; Wang CJ; Lim J; Byun MJ; Kim TH; Park W; Park DH; Kim SN; Park CG
    Biomater Res; 2023 Jan; 27(1):5. PubMed ID: 36721212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
    Tyszka-Czochara M; Konieczny P; Majka M
    J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment.
    Keerthana CK; Rayginia TP; Shifana SC; Anto NP; Kalimuthu K; Isakov N; Anto RJ
    Front Immunol; 2023; 14():1114582. PubMed ID: 36875093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Plasticity of Stem Cells and Macrophages in Cancer.
    Krstic J; Trivanovic D; Jaukovic A; Santibanez JF; Bugarski D
    Front Immunol; 2017; 8():939. PubMed ID: 28848547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for platelets in metabolic reprogramming of tumor-associated macrophages.
    Kang Y; Amoafo EB; Entsie P; Beatty GL; Liverani E
    Front Physiol; 2023; 14():1250982. PubMed ID: 37693009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PFC@O
    Lan Z; Zou KL; Cui H; Chen H; Zhao YY; Yu GT
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints.
    Xu Y; He L; Fu Q; Hu J
    Front Oncol; 2021; 11():759015. PubMed ID: 34858835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.